Navigation Links
ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
Date:3/5/2010

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners.  The Company has successfully commercialized the world's first antisense drug and has 22 drugs in development.  Isis' drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide.  Additional information about Isis is available at www.isispharm.com.

This press release includes forward-looking statements regarding Isis' discovery and development
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
2. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
3. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
4. Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui
5. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
6. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
7. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
8. Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression
9. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
10. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
11. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... NEW YORK , June 17, 2013  A little ... has come under scrutiny by the U.S. Supreme Court – ... on the issue could not have come at a better ... issues that result from the Rx industry tactic are all ... AARP survey of 50+ New Yorkers, state residents are in ...
(Date:6/17/2013)... 2013 Franciscan St. Francis Health Cancer Center ... Indiana to use a new drug ... It,s called Xofigo ®, a radiopharmaceutical used in patients ... It recently was approved for use by the U.S. Food ... advanced stages it may become castration-resistant, which has become resistant ...
(Date:6/17/2013)... WASHINGTON , June 17, 2013  The ... the most comprehensive report on the effectiveness of ... restrictions on these FDA-approved drugs by many state ... more Americans than drunk driving car crashes, an ... and use of heroin. Yet, safe and effective ...
Breaking Medicine Technology:Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 2Supreme Court Ruling on Rx Industry's Pay-to-Delay-Generics Good News for NY Consumers 3New drug proving effective in attacking advanced prostate cancer 2Effective Rx thwarted for deadly opiate epidemic 2
... Into a Collaborative Research Agreement With The University of Texas M. ... Breast ... Cancer, VEDBAEK, ... analysis products, today,announces that it has signed a collaborative research agreement with ...
... Approved in 40 Countries ... ... Massachusetts, May 27, Shire Limited (LSE: SHP, NASDAQ: SHPGY), the,global ... therapy for the treatment of,Hunter syndrome, has been approved by ...
Cached Medicine Technology:Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 2Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
(Date:6/17/2013)... June 17, 2013 "Do you think you ... texting, emailing or using your phone even with a hands ... it is just as dangerous as not using a hands ... of you using Facebook, texting, emailing etc." , ... alters their reflexes that distract the brain, according to a ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Bust’DD (pronounced ‘busted’), ... stylish and well-fitting to women with large busts, will soon ... by two women who understand the problem of ill-fitting bras ... busty women. Their goal is to raise at least $25,000 ... of offering their bras on a wide scale. , In ...
(Date:6/17/2013)... June 17, 2013 The personal ... LLP are pleased to announce that firm Partners ... L. Scher ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will be appearing ... FM) this Sunday, June 23, 2013 at 7a.m. ... guests on Kevin Burke's "Get Active" show, which ...
(Date:6/17/2013)... Park City, Utah (PRWEB) June 17, 2013 ... information on stand-alone HRAs for small businesses ... alternatives to traditional employer sponsored health benefits, is ... health reimbursement arrangements . , According to ... called Health Reimbursement Accounts or HRAs, offer small ...
(Date:6/17/2013)... According to a June 11, 2013 ABC ... and more information surfaces about the negative effects of ... part of one’s skin care routine, as the ... goo.gl/qTKZQ). , “I agree with the article's suggestions for ... Medical Director of Epione Beverly Hills. “Apply a minimum of ...
Breaking Medicine News(10 mins):Health News:Dr. Bonnie Weil Warns Hands Free is Not a Life Saver, It Can Be Just as Much of a Distraction 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2Health News:Zane Benefits Publishes New Information on Stand-Alone HRAs for Small Businesses 2Health News:Skin Care – Answers to Your Sunscreen Questions 2
... connectivity for ... Cardiac Rehabilitation, BOTHELL, ... a global leader in advanced cardiac monitoring,and defibrillation products, announced ... now has seamless connectivity with LUMEDX,CardioWellness(TM) data management software. ...
... as Evelyn Bickley wins CBay,s ,Keys to Medical ... Records ... leading provider,of transcription and healthcare BPO services, today announced the ... year,s AHIMA,Convention and Exhibit in Philadelphia. (Photo: http://www.newscom.com/cgi-bin/prnh/20071017/NEW009 ...
... Inc.,(Nasdaq: ATRC ), a medical device company ... that results reporting on the Company,s,proprietary minimally invasive ... (AF), were published in the Journal of,Cardiovascular Electrophysiology ... from the Oregon Heart and Vascular,Institute. The ...
... WASHINGTON, Oct. 16 Speaker Nancy Pelosi,Senate Majority Leader ... Paul Simon, Families USA, Easter Seals, and other advocates ... Congress to override the,President,s veto of the Children,s Health ... Ron Pollack, to Families USA, to Easter Seals, and ...
... Stock Exchange Symbol: CYT, MONTREAL, Oct. ... leader in cardiac arrhythmia products to treat ... Inc. a patent,infringement lawsuit in the United ... CryoCor makes and sells cryosurgical consoles, ...
... 1st issue of G&D, Dr. Michael Cleary (Stanford University ... as a critical player in the establishment of leukemia ... Mixed lineage leukemia (MLL) is a distinctive type of ... leukemia (ALL) by the presence of a break and ...
Cached Medicine News:Health News:Cardiac Science Announces Data Connectivity with LUMEDX 2Health News:Cardiac Science Announces Data Connectivity with LUMEDX 3Health News:Cardiac Science Announces Data Connectivity with LUMEDX 4Health News:CBaySystems Gives Away 2008 Honda Civic at AHIMA 2007 2Health News:Published Results Using AtriCure Minimally Invasive Products 2Health News:Published Results Using AtriCure Minimally Invasive Products 3Health News:Pelosi: In 48 Hours, Congress Must Choose Between Meeting the Needs of America's Children or Not 2
... Engine is a core software ... System, which enables location-based applications ... Core capabilities of the AeroScout ... positioning, management of AeroScout hardware ...
... Bracelet-ID™ provides a solution for instantaneously ... elopement or unauthorized movement of patients ... a key concern. Certain patients, such ... victims, patients with highly communicable diseases, ...
... Kisses tag is part of the ... Hugs system. The Kisses tag is ... it has been bonded with the ... he two tags remain electronically bonded ...
... small radio transmitter combines state-of-the-art microprocessor ... The tag incorporates a tamper mechanism ... the tag is attached to the ... Heartbeat® signal every 10 seconds to ...
Medicine Products: